News Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 11:20:16 17/04/2026 BST			5-day change	1st Jan Change
1,795.75 ^DKK	+0.32%		+0.31%	-11.42%

04-15	Nordic Equities in North America - Astra Zeneca Gains 0.9 Percent	FW
04-14	Genmab A/S Provides Net Sales of Darzalex Results for the First Quarter of 2026	CI

All News

04-15	Nordic Equities in North America - Astra Zeneca Gains 0.9 Percent	FW
04-14	Genmab A/S Provides Net Sales of Darzalex Results for the First Quarter of 2026	CI
04-14	Major Shareholder Announcement	GL
04-14	Genmab Posts Higher Darzalex Net Sales in Q1	MT
04-14	Genmab Reports Q1 Net Sales of DARZALEX	MT
04-14	Genmab reports Darzalex sales of $3.96 billion in Q1	FW
04-14	Genmab Q1 Darzalex net sales at $3,964 mln	RE
04-14	Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026	GL
04-14	Jyske Bank upgrades Genmab to Buy from Hold, sets price target at DKK 2,300 - BN	FW
04-14	Genmab Combo Therapy Shows Safe Profile in Ovarian Cancer Trial	MT
04-13	Genmab Says Rinatabart Sesutecan Combination Tolerable in Patients With Advanced Ovarian Cancer	MT
04-13	Genmab reports promising safety data in clinical trial	FW
04-13	Genmab says phase 1/2 Rainfol-01 data show Rina-S and bevacizumab combination tolerable	RE
04-13	Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer	BU
04-13	Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer	GL
04-13	Genmab A/S Presents Safety And Tolerability Data Of Rinatabart Sesutecan (Rina-S) In Combination With Bevacizumab In Advanced Ovarian Cancer	CI
04-10	Nordic Equities in North America - Ericsson slips 0.5 percent	FW
04-09	Nordic Equities in North America - Autoliv slips 0.7 percent	FW
04-07	Genmab A/S : AGM 2026 Presentation	PU
04-07	Nordic Stocks in North America - Astra Zeneca rose 2.1 percent	FW
04-02	Nordic Stocks in North America - AstraZeneca Gains 1.8 Percent	FW
04-01	Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons	GL
04-01	Major Shareholder Announcement	GL
04-01	Nordic Equities in North America - Autoliv Gains 0.7 Percent	FW
03-31	Genmab A/S - Major Shareholder Announcement	AQ